Haoxi Health Technology Limited (NASDAQ:HAO) Short Interest Update

Haoxi Health Technology Limited (NASDAQ:HAO) was the target of a large decline in short interest in August. As of August 14th, there was short interest totaling 11,372 shares, a decline of 91.9% from the July 30th total of 140,665 shares. Based on an average trading volume of 346,487 shares, the short-interest ratio is currently 0.0 days. Approximately 3.1% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on HAO shares. Wall Street Zen cut shares of Haoxi Health Technology from a “hold” rating to a “sell” rating in a research note on Sunday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Haoxi Health Technology in a report on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Haoxi Health Technology Stock Performance

Haoxi Health Technology stock traded up $0.48 during mid-day trading on Tuesday, hitting $3.49. 133,898 shares of the company were exchanged, compared to its average volume of 457,045. The business has a fifty day moving average of $9.87 and a 200 day moving average of $1,303.87. Haoxi Health Technology has a 1-year low of $2.70 and a 1-year high of $5,708.80.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.